|
7:00-7:45 AM
|
Registration & Continental Breakfast
|
||||||
|
7:45- 8:00 AM |
Welcome & Introductions – Priya Rao, MD & Ramya Masand, MD
|
||||||
|
8:00 – 8:55 AM |
The New, the Exciting, and the Mundane. Updates in Prostate Cancer Pathology 2025 – Rajal Shah, MD, UT Southwestern Medical Center |
||||||
|
9:00 – 9:55 AM |
Challenges in the Diagnosis of Small Bladder Specimens– Donna Hansel, MD, PhD, The University of Texas MD Anderson Cancer Center
|
||||||
|
9:55 – 10:15 AM |
BREAK |
||||||
|
10:15- 11:10 AM |
Emerging concepts in renal cell carcinoma with emphasis on clinical relevance – Sean Williamson, MD, The Cleveland Clinic |
||||||
|
11:15 – 12:10 PM |
Testicular neoplasms in the 2022 WHO classification: What’s new and what’s already outdated – Andres Acosta, MD, Indiana University Medical Center |
||||||
|
12:10 – 1:15 PM |
LUNCH |
||||||
|
1:15 – 2:10 PM |
Non-neoplastic Lesions in Nephrectomy Specimens with Cancer– Luan Truong, MD, Houston Methodist Hospital
|
||||||
|
2:10 – 2:30 PM |
BREAK |
||||||
|
2:30 – 3:25 PM |
The Utility of Ancillary testing in Genitourinary Tumors – Friend of Foe?– Michelle Hirsch, MD, PhD, Brigham Women’s Hospital
|
||||||
|
3:30 – 4:25 PM |
We have a penile biopsy: Oh! Who knows what to do! – Pheroze Tamboli, MD, The University of Texas MD Anderson Cancer Center |
||||||
|
4:30 – 4:40 PM |
Final Remarks and Adjournment – Priya Rao, MD & Ramya Masand, MD
|
||||||
